DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Bidard F-C, Cottu P, Dubot C. et al.
Anti-HER2 therapy efficacy in HER2-negative metastatic breast cancer with HER2-amplified circulating tumor cells: results of the CirCe T-DM1 trial (117P).
Ann Oncol 2017;
28: v22-v42
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.